Airbnb, VRBO take differing stances on short-term rentals in D.C.
Ahead of Inauguration week in D.C., Airbnb and VRBO are taking vastly different stances on renting in the D.C. area. Melody Hahm explains.
EDMONTON — Alberta is following guidance from a national vaccine advisory panel and increasing the time between COVID-19 doses. Dr. Deena Hinshaw, the province's chief medical officer of health, says the greater lag time will allow more Albertans to be effectively vaccinated sooner. She said the plan is for Alberta to match British Columbia, which announced Monday it will follow the four-month window and get a first dose to everyone who wants one by July. “This change will significantly increase how quickly we can offer Albertans the protection of their first dose,” Hinshaw said Wednesday. “We can all take heart that by getting more first doses to Albertans more quickly, the change I am announcing today brings the light at the end of the tunnel nearer.” Earlier Wednesday, the National Advisory Committee on Immunization recommended first and second doses can be to up to four months apart if supplies are limited. The decision was made based on emerging studies in places including Quebec, the United Kingdom and Israel that show even one dose of vaccine can be about 70 to 80 per cent effective. When vaccines were first available late last year, manufacturers Pfizer-BioNTech and Moderna recommended two shots spaced three to six weeks apart. Alberta is now into its second round of priority vaccinations. The 29,000 highest-risk Albertans, those in long-term care and designated supportive living facilities, have been vaccinated twice. Seniors over 75 and First Nations people 65 and older are among those now allowed to book their shots. Hinshaw said second dose appointments will go ahead for those who have already booked them, and those who want to book a second shot within the previous six-week window will be able to up to March 10. Starting then, those who book a first vaccine dose will have the second one delayed by as much as four months. Newfoundland and Labrador also announced an extension to four months. Manitoba has said it will bring in a delay. Ontario said it was weighing a similar move and seeking advice from the federal government. The change comes as more vaccine doses are on the way. Along with Pfizer-BioNTech and Moderna, the federal government has approved a third vaccine from Oxford-AstraZeneca. Hinshaw said Alberta expects to soon receive shipments of that vaccine as early as next week. Alberta has so far administered 255,000 vaccinations, with 89,000 people getting the full two doses. Hinshaw reported 402 new cases Wednesday. There were 251 people in hospital, 48 of whom were in intensive care. Twelve more people died, bringing that total in the province to 1,902. Case numbers and hospitalizations are a small fraction of what they were at the height of the second wave of COVID-19 in December. The economy remains under public-health restrictions, which include no indoor gatherings and limited capacities for retailers and restaurants. Premier Jason Kenney announced earlier this week a delay in loosening some rules, given unknowns, such as variant strains of the virus. The strains can spread much faster than the original one, with the potential to quickly overwhelm the health system. Alberta has detected 500 variant cases, and Hinshaw announced Wednesday the first variant case at a continuing-care home. Churchill Manor, in Edmonton, has 27 staff and residents who have tested positive, with 19 of them positive for the variant. “Local public-health teams and the operator are taking this outbreak extremely seriously and (are) working closely together to limit spread and protect everyone involved,” said Hinshaw. This report by The Canadian Press was first published March 3, 2021 Dean Bennett, The Canadian Press
RADNOR, Pa. (AP) _ Safeguard Scientifics Inc. (SFE) on Wednesday reported a loss of $7.4 million in its fourth quarter. On a per-share basis, the Radnor, Pennsylvania-based company said it had a loss of 35 cents. Losses, adjusted for asset impairment costs, were 22 cents per share.
(Bloomberg) -- Oil traded near $61 a barrel as investors waited for the outcome of a critical OPEC+ policy meeting later Thursday with no clear steer on how much supply the cartel will return to a fast-tightening market.West Texas Intermediate fell 0.3% after rising 2.6% Wednesday, when prices got a lift from a record drop in U.S. fuel inventories. Group leaders Saudi Arabia and Russia held talks Wednesday seeking common ground on output as Riyadh urges caution but Moscow seeks to raise supply, according to a delegate.Crude has surged this year after the Organization of Petroleum Exporting Countries and its allies slashed collective output to drive a rebalancing of the pandemic-roiled market. The aggressive supply management has helped to drain inventories, while worldwide demand recovers with the roll-out of vaccines. That’s spurred widespread expectations that the single largest actor in the global energy market will now loosen the taps.See also: OPEC+ Silence Has Oil Market Second-Guessing Next MoveVeteran OPEC-watchers still expect some extra barrels from the group, and there’s little chance output will be held at current levels. There are two elements to its debate: first, will the cartel proceed with a 500,000 barrel-a-day collective output hike in April? And second, how will Saudi Arabia phase out the extra cut of 1 million barrels a day it’s been making voluntarily?Heading into the meeting, traders will be mindful that Saudi Arabia has developed a liking for bullish surprises. Energy Minister Prince Abdulaziz bin Salman triggered a surge in prices at the January session by springing a unilateral production cut on an unsuspecting market. Citigroup Inc. has advised its clients not to make bets on this OPEC meeting as “there are too many wildcards,” according to Ed Morse, global head of commodities research.Russian Deputy Prime Minister Alexander Novak outlined his position on Wednesday, saying that while there are many risks including lockdowns, “if we look at the situation, it is much better than a year ago, than in the autumn.”The backdrop to the upcoming gathering is a steady procession of indicators that oil consumption is on the mend. Among recent figures, data showed U.S. commutes are slowly returning to normal as states reopen, while the rate at which people are staying home fell to the lowest since Nov. 12.U.S. government figures on Wednesday showed gasoline inventories sank 13.6 million barrels to 243 million barrels last week after a freeze disrupted the refining sector. At the same time, holdings of crude oil expanded. Brent’s prompt timespread eased to 50 cents a barrel in backwardation on Wednesday. While that remains a bullish pattern -- with near-dated pries above those further out -- it is the lowest reading since Feb. 11.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
The House of Representatives canceled a session on Thursday after intelligence officials warned of a possible threat to the Capitol on Thursday, the date identified by conspiracy theorists that Donald Trump will return to office. As of now, the Senate is still scheduled to return to session at noon on Thursday, with the possibility that […]
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In EHang Holdings Limited To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 3, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against EHang Holdings Limited ("EHang" or the "Company") (NASDAQ:EH) and reminds investors of the April 19, 2021 deadline to seek the role of lead plaintiff in ...
Both sides claim to be in the right and are planning for a court battle.
OTTAWA — The latest news on COVID-19 developments in Canada (all times eastern): 7:20 p.m. Health officials in British Columbia are pleased with a national vaccine panel's endorsement of their approach to wait four months before a second dose of COVID-19 vaccine is offered. The Council of Chief Medical Officers of Health has also given its nod to the province's four-month interval between shots, up from 42 days. Provincial health officer Dr. Bonnie Henry and Health Minister Adrian Dix say setting the booster dose at four months allows more people to access a vaccine, and the wait may even provide longer-lasting protection against COVID-19. British Columbia has recorded 524 new cases of the illness, along with seven more deaths. Two hundred people are now infected with a variant, with the vast majority of cases involving the one first identified in the United Kingdom. --- 6:20 p.m. Alberta says it will begin extending second doses of COVID-19 for up to four months as recommended by the National Advisory Committee on Immunization, starting March 10. The province is reporting 402 new cases and 4,649 active ones. There are 251 people in hospital with the illness. There were 12 more deaths, bringing that total to 1,902. More than 255,000 Albertans have received one or both vaccine doses. --- 5:30 p.m. A national panel of vaccine experts is recommending extending the interval between the two doses of a COVID-19 shot to up to four months. The National Advisory Committee on Immunization says that would help provinces quickly vaccinate more people when faced with a limited supply. The new guidance applies to all COVID-19 vaccines currently approved for use in Canada. Several provinces, including British Columbia and Manitoba, have already indicated they would opt for a four-month interval between doses. --- 5:15 p.m. Quebec is moving more regions into the lower, “orange” pandemic-alert level, including Quebec City and the Eastern Townships, starting on March 8. Premier Francois Legault said today the greater Montreal area will remain in the highest, “red” level, because of fear of novel coronavirus variants. Residents of Quebec City, Chaudiere-Appalaches, Mauricie, Estrie and Centre-du-Quebec will be permitted to eat inside restaurants and go to the gym, and the nighttime curfew will be pushed back from 8 p.m. to 9:30 p.m. Legault is also reporting that Quebec will wait up to four months to administer a second dose of COVID-19 vaccine, up from the current 90-day interval. --- 3:10 p.m. Manitoba expects to receive its first batch of the Oxford-AstraZeneca vaccine by mid-March and plans to target people aged 50 to 64 with high-risk underlying conditions. Dr. Joss Reimer, the medical lead on the province's vaccine task force, says people on dialysis because of kidney failure could be one example, but details are being worked out. Reimer says she is following the advice of a national panel that's recommended against using the Oxford-AstraZeneca shot on people aged 65 and over. Manitoba is focusing on older people with other vaccines. --- 2:55 p.m. Saskatchewan is reporting 121 new cases of COVID-19. Two more residents who were 80 and older have also died. There are 153 people in hospital, with 20 in intensive care. Health officials say around 7,000 more shots of the Pfizer-BioNTech vaccine have arrived and another 7,000 doses are expected by the end of today. To date, around 81,000 vaccinations have been done across the province. --- 2:45 p.m. Yukon Premier Sandy Silver says uptake of COVID-19 vaccines has been "fantastic" as just over half the territory's residents have received their first dose. However, Silver says he's concerned about the rising numbers of variants elsewhere in Canada, even though Yukon currently has no active cases of COVID-19. Chief medical health officer Dr. Brendan Hanley says vaccine hesitancy is a reality and he's urging everyone to get vaccinated at a mass clinic in Whitehorse or through mobile vans that are making their way around Yukon. Seventy-one people have recovered from COVID-19 and one person has died since the pandemic began. --- 2:30 p.m. Nova Scotia is reporting three new cases of COVID-19, and now has 30 known active infections. Health officials say two of the new cases have been identified in the Halifax area and the other in the northern zone. All are close contacts of previously reported cases. As of Tuesday, officials say 35,291 doses of COVID-19 vaccine have been administered, with 13,512 people having received their second dose. --- 2:25 p.m. New Brunswick is reporting three new cases of COVID-19 today. Health officials say two travel-related cases are in the Fredericton area and involve people in their 20s, while the third case is in the Miramichi region and involves a person in their 50s. Officials have identified a list of locations in Miramichi where there may have been public exposures, and a mass testing clinic will be held to determine whether there has been any further spread in the area. There are now 37 active reported cases in the province and three people are hospitalized with the disease, including two in intensive care. --- 2:20 p.m. Health Canada says the Pfizer-BioNTech vaccine can be shipped and stored for up to two weeks in standard freezer temperatures. When it was approved in December, Health Canada said the vaccine had to remain in ultra-low temperatures until just before it is thawed for use. It limited the distribution of the vaccine mainly to bigger urban areas which were equipped with the specialty freezers required. Last week, the companies asked the regulator to make the change after their own data showed their messenger RNA vaccine remained stabled stored for two weeks in -15 C to -25 C. Health Canada says the vaccine can be returned to ultra-low temperatures after being warmed up to the standard freezer temperatures. The change should make it easier for provinces to distribute the vaccine, and could open up the possibility it can go to remote communities and the territories as well. --- 2:05 p.m. Manitoba health officials say they will delay second doses of all vaccines in order to focus on getting first doses to more people more quickly. Dr. Joss Reimer, the medical lead of the province's vaccine task force, says it's in response to studies that show first doses may be more effective than first thought. She says details will be worked out in accordance with a national panel's guidelines, and second-dose appointments already booked will be honoured. --- 1:45 p.m. Ontario will give the newly approved Oxford-AstraZeneca COVID-19 vaccine to residents aged 60 to 64. Solicitor General Sylvia Jones says the province feels the targeted use of that shot will help cut illness and death across Ontario. Jones says the Oxford-AstraZeneca shot will not be administered through mass immunization clinics but through a "different pathway," although she did not elaborate what that would be. Ontario said yesterday it plans to follow the advice of a national panel that's recommended against using the Oxford-AstraZeneca shot on people aged 65 and older. --- 1:35 p.m. Manitoba is reporting 50 additional COVID-19 cases and three deaths. The province is also dropping its age for vaccinations in the general public by one year. Vaccinations can now be booked for First Nations people aged 69 and up and for other people aged 89 and up. --- 1:05 p.m. Prime Minister Justin Trudeau says he's optimistic the timeline to vaccinate Canadians against COVID-19 can be sped up. He says his government's plan to administer COVID-19 shots to all Canadians who want one by the end of September didn't factor in the approval of new drugs. Trudeau says that includes the Oxford-AstraZeneca vaccine, which was delivered today. Canada has received its first 500,000 doses of the shot -- the third COVID-19 vaccine approved for use in the country. --- 1 p.m. Quebec’s statistics agency says life expectancy in the province declined by five months for men and eight months for women between 2019 and 2020. It says the number of deaths reported in the province in 2020 was 10 per cent higher than in 2019 -- an increase of 6,750 deaths. The agency says the decline is largely due to an increase in deaths reported last year during the pandemic. --- 12:45 p.m. Newfoundland and Labrador is extending the interval between the first and second doses of the COVID-19 vaccine to four months. Public health officials announced the new measures Wednesday, saying it will help close to 40,000 more people be vaccinated with a single dose by the end of March. Officials also reported three new cases of COVID-19 Wednesday and said all are linked to previously identified cases. Chief medical officer of health Dr. Janice Fitzgerald said the low case numbers and clear sources of infections are a good sign following the outbreak that spread rapidly through St. John’s in February. --- 11:40 a.m. Prime Minister Justin Trudeau says three federal aid programs designed to blunt the fallout from COVID-19 are being extended. Trudeau says the federal wage subsidy, rent support and lockdown programs will remain in place until June. Finance Minister Chrystia Freeland says all three programs will keep support at the current levels. She says the trio of programs are being extended because the economy is still struggling even with encouraging signs of a recovery on the horizon. --- 11:15 a.m. Prince Edward Island will lift restrictions that closed schools and most businesses at midnight. Premier Dennis King says results from 11,000 COVID-19 tests conducted since the weekend provide confidence that restrictions can be eased. The health orders were imposed after COVID-19 case clusters emerged in Charlottetown and Summerside. Chief medical officer of health Dr. Heather Morrison is reporting one new COVID-19 case today; P.E.I. has 22 active reported infections. --- 11:15 a.m. Quebec is reporting 729 new cases of COVID-19 today and 19 more deaths from the virus, including two within the past 24 hours. Health officials say hospitalizations dropped to 618 and the number of people in intensive care dropped to 120. --- 10:30 a.m. Ontario is reporting 958 new COVID-19 cases today. The province says 17 more people have died from the virus. More than 27,000 tests were completed to compile the data. The province says 27,398 COVID-19 vaccine doses were administered since the last daily update. --- This report by The Canadian Press was first published March 3, 2021. The Canadian Press
In a competitive situation, ABC Signature has optioned Rebekah Taussig’s memoir Sitting Pretty: The View from My Ordinary Resilient Disabled Body. It will be developed for television by ABC Signature and studio-based Mandeville Films and director-producer Randall Einhorn’s Sad Unicorn banner. Taussig will co-write the adaptation with another writer. She will executive produce, along with […]
A Senate committee on Wednesday approved a bill that would penalize companies that perform poorly on state contracts, a reaction to the various contracting scandals that have erupted in the state government in recent years.
A swell of COVID-19 cases is halting samba steps in Brazil's biggest metropolis while Argentina's capital tiptoes its way back to the tango floor. The two biggest cities in each of the neighboring South American countries are headed in opposite directions, reflecting how those that loosen restrictions despite warnings from scientists see a spike in the pandemic while others that keep social distancing measures in place are able to reopen their economies sooner. Sao Paulo, home to almost 12 million people, is bracing for the worst two weeks yet in the pandemic and the growing risk that its once-resilient health care system will collapse, Gov. João Doria told reporters Wednesday.
A murder probe has been launched after a teenager was stabbed to death in south London. The victim, believed to be aged 19, was pronounced dead at the scene after he suffered multiple knife wounds. Police were called at just after midnight on Wednesday to the scene in Alpha Road, Croydon.
The Japanese yen hit a seven-month low on the dollar on Thursday as hopes that vaccine distribution and more government stimulus will drive the U.S. economy into a solid rebound lifted the greenback and benchmark Treasury yields. But the creep up in benchmark yields may weigh on Asian stocks, as wary investors recall last week's sell-off in government bonds that caused yields to spike, spooking equity markets and causing shares to tumble. U.S. shares had fallen overnight as investors sold off high-flying technology shares to focus on other sectors likely to benefit from an economic recovery.
KINGSTON, ON, March 3, 2021 /CNW/ - The Empire Life Insurance Company ("Empire Life" or the "Company") (TSX: EML.A) today announced that it will exercise its right to redeem all of its 5,980,000 outstanding Non-Cumulative Rate Reset Preferred Shares, Series 1 (the "Preferred Shares Series 1") on Saturday, April 17, 2021 at the price of $25.
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Ebix To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 3, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ebix, Inc. ("Ebix" or the "Company") (NASDAQ:EBIX) and reminds investors of the April 23, 2021 deadline to seek the role of lead plaintiff in a federal securities ...
‘This is only the beginning – I plan to approach the federal arena with a bill that will protect youth across the nation in these types of facilities,’ the socialite says
(Bloomberg) -- Asian stocks fell with U.S. futures Thursday after an overnight surge in bond yields once more dragged down shares on Wall Street. The dollar strengthened and benchmark Treasury yields ticked higher.Stocks dropped in Japan, South Korea and Australia, while S&P 500 futures saw modest declines. Earlier, the Nasdaq 100 slumped to a two-month low and the S&P 500 extended its slide into a second day. A selloff in high-flying giants such as Apple Inc. and Amazon.com Inc. outweighed gains in banks and energy producers.Australian bonds slumped after benchmark Treasury yields approached 1.5% on Thursday, and a market gauge of inflation expectations over the next five years hit its highest level since 2008. Traders also assessed data pointing to a slow and uneven economic recovery from the depths of the pandemic. Oil extended losses.The selloff in Treasuries has rattled nerves across the globe amid warnings of excessive investor optimism in stocks. Policy makers still appear reluctant to step in to buy more longer-dated bonds, with focus turning to Federal Reserve Chairman Jerome Powell’s upcoming comments. Chicago Fed President Charles Evans said Wednesday he shared the view that the recent rise in yields was healthy.“Inflation is a concern; there is a lot of money sloshing around the system and it makes sense to have some sort of a correction right now,” said Shana Sissel, Spotlight Asset Group chief investment officer. “And bond yields going up is the market’s implicit way of tightening since the Fed has made it clear they don’t have the intention of doing so.” Read: U.S. Inflation Expectations Hit Decade High as Yields ResurgeData Wednesday showed that growth at U.S. service providers slowed to a nine-month low in February. Meanwhile, the number of employees at U.S. businesses rose by less than expected, underscoring the jobs market’s struggle to recover despite a decline in Covid-19 infections in recent weeks.The U.S. economy expanded modestly in the first two months of the year and sentiment among business owners is picking up as vaccinations bolster the prospects for growth, according to the Federal Reserve’s Beige Book. Democratic leaders in the Senate are working to consolidate support for the $1.9 trillion stimulus bill.Elsewhere, oil retreated on a government report showing a record drop in domestic fuel inventories following a deep freeze that shuttered refineries in the U.S. South.Some key events to watch this week:OPEC+ meeting on output Thursday.U.S. factory orders, initial jobless claims and durable goods orders are due Thursday.The February U.S. employment report on Friday will provide an update on the speed and direction of the nation’s labor market recovery.These are some of the moves in markets:StocksS&P 500 futures fell 0.4% as of 9:07 a.m. in Tokyo. The S&P 500 fell 1.3%. The Nasdaq 100 lost 2.9%.Topix index fell 0.7%.Australia’s S&P/ASX 200 Index fell 1.2%.Kospi index fell 1.3%.Hang Seng Index futures fell 0.9% earlier.CurrenciesThe yen traded at 107.03 per dollar.The offshore yuan was at 6.4781 per dollar.The Bloomberg Dollar Spot Index gained 0.1%.The euro traded at $1.2056, down 0.1%.BondsThe yield on 10-year Treasuries was steady at 1.49% after rising nine basis points.Australia’s 10-year bond yield rose 10 basis points to 1.77%.CommoditiesWest Texas Intermediate crude fell 0.8% to $60.79 a barrel.Gold was at $1,711.40 an ounce after sliding.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
NEW YORK, March 03, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AstraZeneca PLC (NASDAQ: AZN) between May 21, 2020 and November 20, 2020, inclusive (the "Class Period"), of the important March 29, 2021 lead plaintiff deadline. SO WHAT: If you purchased AstraZeneca securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the AstraZeneca class action, go to http://www.rosenlegal.com/cases-register-2027.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 29, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) initial clinical trials for AZD1222, the Company’s coronavirus vaccine hopeful, had suffered from a critical manufacturing error, resulting in a substantial number of trial participants receiving half the designed dosage; (2) clinical trials for AZD1222 consisted of a patchwork of disparate patient subgroups, each with subtly different treatments, undermining the validity and import of the conclusions that could be drawn from the clinical data across these disparate patient populations; (3) certain clinical trial participants for AZD1222 had not received a second dose at the designated time points, but rather received the second dose up to several weeks after the dose had been scheduled to be delivered according to the original trial design; (4) AstraZeneca had failed to include a substantial number of patients over 55 years of age in its clinical trials for AZD1222, despite this patient population being particularly vulnerable to the effects of COVID-19 and thus a high priority target market for the drug; (5) AstraZeneca’s clinical trials for AZD1222 had been hamstrung by widespread flaws in design, errors in execution, and a failure to properly coordinate and communicate with regulatory authorities and the general public; (6) as a result of the foregoing, the clinical trials for AZD1222 had not been conducted in accordance with industry best practices and acceptable standards and the data and conclusions that could be derived from the clinical trials was of limited utility; and (7) as a result of the foregoing, AZD1222 was unlikely to be approved for commercial use in the United States in the short term, one of the largest potential markets for the drug. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the AstraZeneca class action, go to http://www.rosenlegal.com/cases-register-2027.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq.Phillip Kim, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) 202-3827lrosen@rosenlegal.compkim@rosenlegal.comcases@rosenlegal.comwww.rosenlegal.com
VAUGHAN, ON, March 3, 2021 /CNW/ - Recipe Unlimited Corporation will be releasing 2020 fourth quarter and year-end financial results on SEDAR (www.com) after the close of markets on Thursday, March 4th, 2021.
Republicans in 43 states have introduced more than 250 bills restricting voting rights, underscoring urgency in Congress to pass sweeping elections legislation, Alex Woodward reports
CAPE CANAVERAL, Fla. — SpaceX’s futuristic Starship finally aced a touchdown Wednesday after two previous tries ended in massive fireballs. The full-scale prototype soared more than 6 miles (10 kilometres) after lifting off from the southern tip of Texas. It descended horizontally over the Gulf of Mexico and then flipped upright just in time to land. This time, the shiny bullet-shaped rocketship remained intact, prompting SpaceX commentator John Insprucker to declare, “third time’s a charm as the saying goes.” “We've had a successful soft touchdown on the landing pad," he added. SpaceX founder Elon Musk plans to use Starships to send people to the moon and Mars. The last two prototypes reached a similarly high altitude in December and February, but slammed into the ground at Boca Chica, Texas, and exploded. There's another test flight planned soon. Each of these last three test flights lasted 6 1/2 minutes. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. Marcia Dunn, The Associated Press